InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,537.02
(
0.51%
)
US TECH 100
19,634.80
(
0.80%
)
Dow Jones
39,308.00
(
-0.06%
)
Brent Oil
86.83
(
-0.10%
)
Bitcoin
60,172.40
(
0.01%
)
Post# of 252477
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

biomaven0

Send PM Follow Ignore
Followers 82
Posts 4778
Boards Moderated 0
Alias Born 02/27/2007

biomaven0

Re: DewDiligence post# 210882

Wednesday, 04/26/2017 7:30:05 PM

Wednesday, April 26, 2017 7:30:05 PM

Post# of 252477
The primary driver of FGEN (by far) is going to be roxadustat safety. (There is some potential volatility from their ctgf drug of course, but that's not relevant to the discussion).

If roxa has a safety issue of some sort, I'd predict it's 50:50 whether AKBA would go up or down on the news. In my book, that makes it a bad hedge.

Peter
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up